Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: ValuEngine, Inc.
$25.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

OptimizeRx Corp Announces Shad Stastney As New Chief Executive Officer And Chairman


Monday, 14 Jan 2013 08:00am EST 

OptimizeRx Corp announced that Board of Directors has named Shad Stastney the Company's Chief Executive Officer and Chairman. 

Company Quote

0.86
-0.02 -2.27%
21 Nov 2014